Peeter Padrik

The paper evaluates a genetic risk-based breast cancer screening model in younger women, showing its feasibility, clinical utility, and acceptability.

The paper evaluates a genotype-first approach for identifying BRCA1/2 variant carriers in a biobank cohort and assesses the impact of risk disclosure.

The paper develops a polygenic risk score-based pipeline to provide personalized recommendations for melanoma prevention by integrating genetic risk with health behavior.

This paper constructs a polygenic risk score (PRS) model for prostate cancer risk prediction and develops personalized screening recommendations using population-specific data.

This paper develops a sex-specific polygenic risk score model for colorectal cancer screening, showing it can stratify risk and inform individualized screening recommendations.

The paper revalidates a polygenic risk score (PRS) model for breast cancer risk prediction and develops a pipeline for individualized screening recommendations using population-specific data.

This paper compares genetic risk scores for breast cancer, finding that a combined metaGRS2 provides the strongest predictive ability in two cohorts.